Moderna, Inc. financial data

Symbol
MRNA on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 391 % -0.73%
Quick Ratio 11.6 % -12%
Debt-to-equity 28.5 % -12.3%
Return On Equity -31.4 % -77.6%
Return On Assets -24.4 % -83.1%
Operating Margin 4.82 % -92.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 391M shares +1.52%
Common Stock, Shares, Outstanding 391M shares +1.56%
Entity Public Float 42.1B USD +4.73%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 390M shares +1.3%
Weighted Average Number of Shares Outstanding, Diluted 390M shares -2.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10.7B USD -53.7%
Revenue from Contract with Customer, Excluding Assessed Tax 2.23B USD -56.1%
Research and Development Expense 3.48B USD -27.9%
General and Administrative Expense 1.06B USD -17.9%
Costs and Expenses 5.7B USD -26.7%
Operating Income (Loss) -3.46B USD -28.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.15B USD -34%
Income Tax Expense (Benefit) -37M USD +71.3%
Net Income (Loss) Attributable to Parent -3.12B USD -40.1%
Earnings Per Share, Basic -8 USD/shares -40.3%
Earnings Per Share, Diluted -8 USD/shares -40.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.13B USD -31.1%
Accounts Receivable, after Allowance for Credit Loss, Current 1.05B USD -33.1%
Inventory, Net 332M USD -19.4%
Other Assets, Current 56M USD +21.7%
Assets, Current 6.6B USD -31.7%
Deferred Income Tax Assets, Net 81M USD 0%
Operating Lease, Right-of-Use Asset 738M USD -5.87%
Goodwill 52M USD 0%
Other Assets, Noncurrent 530M USD -4.68%
Assets 12.1B USD -23.2%
Accounts Payable, Current 267M USD -28.4%
Employee-related Liabilities, Current 310M USD +27%
Accrued Liabilities, Current 1.18B USD -14.4%
Contract with Customer, Liability, Current 163M USD -57%
Liabilities, Current 1.68B USD -23.6%
Contract with Customer, Liability, Noncurrent 157M USD +65.3%
Deferred Income Tax Liabilities, Net 239M USD -0.83%
Operating Lease, Liability, Noncurrent 660M USD -2.8%
Other Liabilities, Noncurrent 281M USD +1.81%
Liabilities 2.81B USD -27.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 27M USD +145%
Retained Earnings (Accumulated Deficit) 8.05B USD -27.9%
Stockholders' Equity Attributable to Parent 9.33B USD -21.8%
Liabilities and Equity 12.1B USD -23.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.04B USD -4.85%
Net Cash Provided by (Used in) Financing Activities 4M USD -71.4%
Net Cash Provided by (Used in) Investing Activities 730M USD +519%
Common Stock, Shares Authorized 1.6B shares 0%
Common Stock, Shares, Issued 391M shares +1.56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -303M USD +64.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.13B USD -31.1%
Deferred Tax Assets, Valuation Allowance 3.08B USD +38.7%
Deferred Tax Assets, Gross 3.36B USD +25.5%
Operating Lease, Liability 677M USD -3.29%
Payments to Acquire Property, Plant, and Equipment 117M USD -40.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.1B USD -54.8%
Lessee, Operating Lease, Liability, to be Paid 1.09B USD -6.46%
Operating Lease, Liability, Current 17M USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 78M USD +6.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 73M USD +2.82%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 409M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 81M USD +3.85%
Deferred Tax Assets, Operating Loss Carryforwards 424M USD +371%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 162M shares 0%
Unrecognized Tax Benefits 240M USD +3.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 82M USD +1.24%
Additional Paid in Capital 1.25B USD +67%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 204M USD -38%
Deferred Tax Assets, Net of Valuation Allowance 277M USD -39%
Share-based Payment Arrangement, Expense 474M USD +17.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%